» Articles » PMID: 18668339

Early-life Events May Trigger Biochemical Pathways for Alzheimer's Disease: the "LEARn" Model

Overview
Journal Biogerontology
Specialty Geriatrics
Date 2008 Aug 1
PMID 18668339
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD), the most common form of dementia among the elderly, manifests mostly late in adult life. However, it is presently unclear when the disease process starts and how long the pathobiochemical processes take to develop. Our goal is to address the timing and nature of triggers that lead to AD. To explain the etiology of AD, we have recently proposed a "Latent Early-life Associated Regulation" (LEARn) model, which postulates a latent expression of specific genes triggered at the developmental stage. This model integrates both the neuropathological features (e.g., amyloid-loaded plaques and tau-laden tangles) and environmental factors (e.g., diet, metal exposure, and hormones) associated with the disease. Environmental agents perturb gene regulation in a long-term fashion, beginning at early developmental stages, but these perturbations do not have pathological results until significantly later in life. The LEARn model operates through the regulatory region (promoter) of the gene and by affecting the methylation status within the promoter of specific genes.

Citing Articles

Perinatal S-Adenosylmethionine Supplementation Represses Expression by the Cellular Epigenetic Memory of CpG and Non-CpG Methylation in Adult TgCRD8 Mice.

Raia T, Armeli F, Cavallaro R, Ferraguti G, Businaro R, Lucarelli M Int J Mol Sci. 2023; 24(14).

PMID: 37511434 PMC: 10380323. DOI: 10.3390/ijms241411675.


Prostaglandin EP2 receptor antagonist ameliorates neuroinflammation in a two-hit mouse model of Alzheimer's disease.

Banik A, Amaradhi R, Lee D, Sau M, Wang W, Dingledine R J Neuroinflammation. 2021; 18(1):273.

PMID: 34801055 PMC: 8605573. DOI: 10.1186/s12974-021-02297-7.


Charting the life course: Emerging opportunities to advance scientific approaches using life course research.

Hanson H, Leiser C, Bandoli G, Pollock B, Karagas M, Armstrong D J Clin Transl Sci. 2021; 5(1):e9.

PMID: 33948236 PMC: 8057465. DOI: 10.1017/cts.2020.492.


Understanding the Link Between Maternal Overnutrition, Cardio-Metabolic Dysfunction and Cognitive Aging.

Peleg-Raibstein D Front Neurosci. 2021; 15:645569.

PMID: 33716660 PMC: 7953988. DOI: 10.3389/fnins.2021.645569.


Summary-Based Methylome-Wide Association Analyses Suggest Potential Genetically Driven Epigenetic Heterogeneity of Alzheimer's Disease.

Nazarian A, Yashin A, Kulminski A J Clin Med. 2020; 9(5).

PMID: 32429084 PMC: 7290473. DOI: 10.3390/jcm9051489.


References
1.
Barker D, Eriksson J, Forsen T, Osmond C . Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol. 2003; 31(6):1235-9. DOI: 10.1093/ije/31.6.1235. View

2.
Lahiri D, Farlow M, Sambamurti K, Greig N, Giacobini E, Schneider L . A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease. Curr Drug Targets. 2003; 4(2):97-112. DOI: 10.2174/1389450033346957. View

3.
Sambamurti K, Suram A, Venugopal C, Prakasam A, Zhou Y, Lahiri D . A partial failure of membrane protein turnover may cause Alzheimer's disease: a new hypothesis. Curr Alzheimer Res. 2006; 3(1):81-90. DOI: 10.2174/156720506775697142. View

4.
Lahiri D, Chen D, Ge Y, Bondy S, Sharman E . Dietary supplementation with melatonin reduces levels of amyloid beta-peptides in the murine cerebral cortex. J Pineal Res. 2004; 36(4):224-31. DOI: 10.1111/j.1600-079X.2004.00121.x. View

5.
Lahiri D, Ge Y, Maloney B, Wavrant-De Vrieze F, Hardy J . Characterization of two APP gene promoter polymorphisms that appear to influence risk of late-onset Alzheimer's disease. Neurobiol Aging. 2005; 26(10):1329-41. DOI: 10.1016/j.neurobiolaging.2004.11.005. View